SELLAS Life Sciences Group (RXK3.F) Q2 2024 Earnings

14MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.19
-0.18
-0.16
-0.15

Details

Expected EPS
-0.1479488
Actual EPS
-0.1941828
Surprise EPS
-0.05
Surprise Percent
+31.25%

Description

SELLAS Life Sciences Group (RXK3.F) has reported earnings of -0.1941828 per share for Q2 2024.

0 Comments

Share your thoughts